| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/2010 | US20100183735 Method for inducing selectively suppressed immune response to transplanted tissue or cells |
| 07/22/2010 | US20100183727 Immunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen |
| 07/22/2010 | US20100183708 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183707 Methods and compositions for treating hiv infection |
| 07/22/2010 | US20100183706 Peptide epitopes of apolipoprotein b |
| 07/22/2010 | US20100183702 Therapies For Cancer Using RLIP76 |
| 07/22/2010 | US20100183700 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 07/22/2010 | US20100183685 Tumor and infectious disease therapeutic compositions |
| 07/22/2010 | US20100183684 Oral vaccination |
| 07/22/2010 | US20100183683 Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods |
| 07/22/2010 | US20100183682 Method of treating allergies using tgf-beta1 and allergens |
| 07/22/2010 | US20100183681 treating a food allergy; orally administer 100 mu g/kg or more of transforming growth factor-beta (TGF- beta ); no side effects |
| 07/22/2010 | US20100183680 Purified Plasmodium and Vaccine Compositions |
| 07/22/2010 | US20100183679 Primers for detecting plasmodium |
| 07/22/2010 | US20100183678 Conjugates of plasmodium falciparum surface proteins as malaria vaccines |
| 07/22/2010 | US20100183677 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183676 Compositions comprising opa protein epitopes |
| 07/22/2010 | US20100183675 Stable vaccine compositions and methods of use |
| 07/22/2010 | US20100183674 immunization; comprised of a fusion protein; bioterrorism; plague |
| 07/22/2010 | US20100183673 Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| 07/22/2010 | US20100183672 Process for preparing live smallpox vaccine |
| 07/22/2010 | US20100183671 Low-additive influenza vaccines |
| 07/22/2010 | US20100183670 Method for identifying motifs and/or combinations of motifs having a boolean state of predetermined mutation in a set of sequences and its application |
| 07/22/2010 | US20100183669 Mannose immunogens for HIV-1 |
| 07/22/2010 | US20100183668 Use of coccidian |
| 07/22/2010 | US20100183667 Vaccine Comprising an Oil in Water Emulsion Adjuvant |
| 07/22/2010 | US20100183666 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 07/22/2010 | US20100183665 Promoterless cassettes for expression of alpha virus structural proteins |
| 07/22/2010 | US20100183664 Attenuated recombinant newcastle disease virus and vaccine containing the same |
| 07/22/2010 | US20100183663 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 07/22/2010 | US20100183662 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
| 07/22/2010 | US20100183659 Allergen formulation |
| 07/22/2010 | US20100183658 Novel Compounds for Enhancing MHC Class II Therapies |
| 07/22/2010 | US20100183657 Fusion proteins of mycobacterium tuberculosis |
| 07/22/2010 | US20100183656 Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| 07/22/2010 | US20100183655 Immunogenic Protein Constructs |
| 07/22/2010 | US20100183654 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 07/22/2010 | US20100183653 Fusion Proteins Comprising CD4 Minimal Modules and Methods of Use Thereof |
| 07/22/2010 | US20100183652 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 07/22/2010 | US20100183651 Broadly Representative Antigen Sequences and Method for Selection |
| 07/22/2010 | US20100183650 Antigen Delivery Vectors and Constructs |
| 07/22/2010 | US20100183649 Method of producing virus-like particles of picornavirus using a small-ubiquitin-related fusion protein expression system |
| 07/22/2010 | US20100183648 Vaccine antigen capable of inducing cross-reacting and neutralizing antibody againts high-risk-type human papillomavirus |
| 07/22/2010 | US20100183647 Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor |
| 07/22/2010 | US20100183646 Mage-a3/hpv 16 peptide vaccines for head and neck cancer |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183644 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100183643 Cancer vaccines containing epitopes of oncofetal antigen |
| 07/22/2010 | US20100183642 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 07/22/2010 | US20100183641 Sperm ligands and methods of use |
| 07/22/2010 | US20100183640 Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| 07/22/2010 | US20100183639 Nucleic acid-lipophilic conjugates |
| 07/22/2010 | US20100183638 Restrictive agonist of toll-like receptor 3 (tlr3) |
| 07/22/2010 | US20100183637 fusion molecule based on novel taa variant |
| 07/22/2010 | US20100183636 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 07/22/2010 | US20100183635 Glycosylated specificity exchangers |
| 07/22/2010 | US20100183634 Multifunctional nucleic acid nano-structures |
| 07/22/2010 | US20100183633 Interleukin 6 and tumor necrosis factor alpha as biomarkers of jnk inhibition |
| 07/22/2010 | US20100183632 Antibody Therapy For Modulating Function Of Intestinal Receptors |
| 07/22/2010 | US20100183631 Antibodies Directed to HER-3 and Uses Thereof |
| 07/22/2010 | US20100183630 Tat-005 and Methods of Assessing and Treating Cancer |
| 07/22/2010 | US20100183629 Antagonists of endothelial differentiation gene subfamily 3 (edg-3, s1p3) receptors for prevention and treatment of ocular disorders |
| 07/22/2010 | US20100183628 Random homozygous gene perturbation (rhgp) with thermal assymetric interlaced (tail)-pcr |
| 07/22/2010 | US20100183627 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 07/22/2010 | US20100183626 Human phospholipase a2 epsilon |
| 07/22/2010 | US20100183625 Treatment of Mucositis with Kallikrein Inhibitors |
| 07/22/2010 | US20100183624 Methods for increasing adiponectin |
| 07/22/2010 | US20100183623 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 07/22/2010 | US20100183622 Vpr function and activity |
| 07/22/2010 | US20100183621 Fully human antibodies against human 4-1BB |
| 07/22/2010 | US20100183620 Compositions and methods for regulating collagen and smooth muscle actin expression by serpine2 |
| 07/22/2010 | US20100183619 Neutralizing Antibodies and Methods of Use Thereof |
| 07/22/2010 | US20100183618 Anti-epha2 antibody |
| 07/22/2010 | US20100183617 Compositions and methods for regulating sas1r |
| 07/22/2010 | US20100183616 Antibodies against interleukin-1 beta |
| 07/22/2010 | US20100183615 Cross-species-specific bispecific binders |
| 07/22/2010 | US20100183614 Immunoglobulins directed to bacterial, viral and endogeneous polypeptides |
| 07/22/2010 | US20100183613 Methods of using mevalonate decarboxylase (mvd) antagonists |
| 07/22/2010 | US20100183612 Methods of treatment using ctla4 mutant molecules |
| 07/22/2010 | US20100183611 Targeted cryptosporidium biocides |
| 07/22/2010 | US20100183610 Genetic polymorphisms associated with alzheimer's disease, methods of detection and uses thereof |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183608 Drg11-responsive (dragon) gene and uses thereof |
| 07/22/2010 | US20100183607 Risk markers for cardiovascular disease |
| 07/22/2010 | US20100183606 Monocyclic heterocycles as kinase inhibitors |
| 07/22/2010 | US20100183605 Tes7 and antibodies that bind thereto |
| 07/22/2010 | US20100183604 Preventive/remedy for cancer |
| 07/22/2010 | US20100183603 Compositions and Methods for the Treatment of Cancer |
| 07/22/2010 | US20100183602 Induction of Tolerogenic Phenotype in Mature Dendritic Cells |
| 07/22/2010 | US20100183601 Combination of Aurora Kinase Inhibitors and Anti-CD20 Antibodies |
| 07/22/2010 | US20100183600 RAF Inhibitors and Their Uses |
| 07/22/2010 | US20100183599 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/22/2010 | US20100183598 Methods of treating cardiovascular disorders |
| 07/22/2010 | US20100183597 Drak2 expression is associated with diabetes |
| 07/22/2010 | US20100183596 Virulence Factors of Streptoccus Pnuemoniae |
| 07/22/2010 | US20100183595 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 07/22/2010 | US20100183594 Steroid-sparing methods of treating brain edema |
| 07/22/2010 | US20100183593 Gene Polymorphisms Predictive for Dual TKI Therapy |
| 07/22/2010 | US20100183592 Human epo receptor agonists, compositions, methods and uses for preventing or treating glucose intolerance related conditions |
| 07/22/2010 | US20100183591 Modulation of nkg2d |